Sign in

Tanya McNally

Chief People Officer at CENTENECENTENE
Executive

About Tanya McNally

Centene’s Chief People Officer (CPO) since March 2023, Tanya M. McNally (age 51) oversees human capital strategy and enterprise people programs; she served as Interim CPO (Jan–Mar 2023) after joining Centene via WellCare in 2018 and rising through HR leadership roles . During her CPO tenure, Centene delivered 2024 total revenues of $163B (+6% YoY), GAAP diluted EPS of $6.31 (+27% YoY), adjusted diluted EPS of $7.17 (+7% YoY), and a 3-year TSR CAGR of -10% as disclosed in the 2025 proxy; incentive plans tied payouts primarily to adjusted EPS and quality/enterprise goals . Her insider Form 3 (Feb 18, 2025) shows meaningful unvested RSUs and PSUs, indicating retention hooks through 2026–2027 and potential vesting-related trading windows in Mar/Apr 2025 and Jan 2026 .

Past Roles

OrganizationRoleYearsStrategic impact
CenteneChief People OfficerMar 2023–presentLeads enterprise human capital; plan sponsor/executive signatory for Amended & Restated Executive Severance and Change in Control Plan (administered by Compensation & Talent Committee) .
CenteneInterim Chief People OfficerJan 2023–Mar 2023Transition leadership of People function .
CenteneRegional VP, Human ResourcesMay 2022–Dec 2022Regional HR leadership .
CenteneVP, Global HR Business PartnerJan 2020–May 2022Enterprise HR business partnering .
WellCare Health Plans (acquired by Centene)VP, Human ResourcesAug 2018–Jan 2020HR leadership prior to combination .

External Roles

  • No public company directorships or external board roles disclosed for McNally in Centene’s 2025 proxy or 2024/2025 10-K executive officer sections .

Fixed Compensation

Not disclosed in the 2025 Proxy’s Named Executive Officer (NEO) tables (McNally is not listed as a 2024 NEO). Base salary and bonus target figures for the CPO were not provided in proxy or 8-Ks reviewed .

Performance Compensation

Centene’s executive annual incentive and long-term incentive frameworks (applying to NEOs and generally to senior executives) emphasize pay-for-performance.

  • Annual Cash Incentive Plan design and 2024 outcomes (company-level):

    • Metrics/weights: Adjusted diluted EPS (65%); Enterprise & Individual Goals (25%); Quality Goals (10%) .
    • 2024 payout results: EPS achieved 167% of target (weighted 108.6%); Enterprise & Individual 130% (32.5%); Quality 169% (16.9%); Total payout 158% of target .
  • PSU design for current program:

    • Metrics/weights for PSUs: Adjusted Pre-Tax Earnings Growth CAGR (34%); Average Adjusted Pre-tax Earnings Margin (33%); Relative TSR (33%) .
    • Historical cycle example (2022–2024): Weighted payout 44.6% of target (driven by metric-level outcomes disclosed) .

2024 Annual Cash Incentive Plan Results

MetricWeightActual vs. TargetWeighted Payout %
Adjusted Diluted EPS65%167%108.6%
Enterprise & Individual Goals25%130%32.5%
Quality Goals10%169%16.9%
Total100%158%

Long-Term Incentive Design (PSUs)

PSU MetricWeightNotes
Adjusted Pre-Tax Earnings Growth CAGR34%Company financial metric focus .
Average Adjusted Pre-tax Earnings Margin33%Profitability quality metric .
Relative TSR33%Market-relative alignment .

Equity Ownership & Alignment

  • Ownership policies and risk controls:
    • Executives are subject to stock ownership guidelines (CEO 6x base salary; other NEOs 3x) and clawbacks; hedging and pledging are prohibited .
    • Equity awards are double-trigger for change-in-control; no single-trigger employment agreements or stock grants .

Beneficial Ownership and Outstanding Awards (as of Feb 18, 2025)

ItemDetail
Common stock beneficially owned (Form 3)28,745 shares D (direct) .
Included RSUs (unvested)14,037 RSUs within beneficial ownership .
Additional PSUs (unvested)9,765 PSUs outstanding (not included in 28,745), subject to 3-year performance conditions; grants on Mar 15, 2023 (2,073) and Mar 15, 2024 (7,692) .
Hedging/PledgingProhibited for executives .

RSU Vesting Schedule Detail (from Form 3)

Vest date(s)SharesNotes
Mar 15, 2025809Single-tranche vest .
Mar 15, 2025; 2026; 20274,142 totalVests in three equal annual installments starting Mar 15, 2025 .
Mar 15, 2025; 20262,566 totalVests in two equal annual installments starting Mar 15, 2025 .
Apr 15, 2025; 20264,897 totalVests in two equal annual installments starting Apr 15, 2025 .
Jan 15, 20261,623Single-tranche vest .

Implication: Concentrated vesting windows in Mar/Apr 2025 and Jan/Apr 2026 create potential sell‑to‑cover activity typical for tax withholding; PSUs add performance-contingent retention through 2026–2027 .

Employment Terms

  • Executive severance and change-in-control plan (company-wide framework; CPO executed company signatory):
    • Administered by the Compensation & Talent Committee; plan sponsor/agent for service includes the Chief People Officer; plan updated/amended with company execution “By: /s/ Tanya McNally” .
    • Double-trigger CoC: cash severance plus equity acceleration upon qualifying termination post-CoC; no excise tax gross-ups .

Executive Severance and Change-in-Control Plan Summary

ScenarioTier I (EVP/SVP)Tier II (Market/BU CEO)Tier III (Other)
Qualifying termination (not CoC)1x base salary + prorated target bonus; equity continued vesting 12 months; CLTIP prorated @ actual; 12 months COBRA; 6 months outplacement .1x base salary + prorated target bonus; equity continued vesting 12 months; CLTIP prorated @ actual; 12 months COBRA; 6 months outplacement .0.75x base salary + prorated target bonus; equity continued vesting 9 months; CLTIP prorated @ actual; 9 months COBRA; 6 months outplacement .
CoC qualifying termination (double‑trigger)2x base + 2x average bonus + prorated target bonus; full equity acceleration; CLTIP full vest; 18 months COBRA; 6 months outplacement .1.5x base + 1.5x average bonus + prorated target bonus; full equity acceleration; CLTIP full vest; 18 months COBRA; 6 months outplacement .1x base + 1x average bonus + prorated target bonus; full equity acceleration; CLTIP full vest; 12 months COBRA; 6 months outplacement .

Note: McNally’s specific tier classification was not disclosed in filings reviewed; terms above reflect plan-level benefits by tier .

  • Clawback policy: Company can recover performance-based cash and equity in specified circumstances .

Performance & Track Record (Company context during McNally’s tenure)

Metric2024YoY/CAGR
Total Revenues ($B)163+6% YoY .
GAAP Diluted EPS6.31+27% YoY .
Adjusted Diluted EPS7.17+7% YoY; 3-year CAGR 12% (Adj EPS) .
3-Year TSR CAGR(10)%As disclosed in proxy .
  • Operational achievements cited by management and Board:
    • Improved Medicare Star Ratings; positioning Medicare business to breakeven in 2027 .
    • Marketplace growth and fraud/waste/abuse integrity initiatives; #1 Marketplace carrier with ~4.4M members .
    • Medicaid redetermination navigation with strong RFP renewals; largest US Medicaid MCO .

Compensation Structure Analysis

  • Alignment mechanisms: Heavily weighted EPS and profitability in annual and long-term metrics; relative TSR in PSUs aligns to shareholder outcomes .
  • Risk controls: No single-trigger equity; no hedging/pledging; clawbacks; independent consultant advises committee .
  • 2024 incentive outcomes: Elevated annual payout (158% of target) vs negative 3-year TSR could draw investor scrutiny on metric mix/targets despite strong operational/financial execution .

Investment Implications

  • Retention and selling pressure: Unvested RSUs and PSUs across 2025–2027 create retention incentives and near-term vesting events (Mar/Apr 2025; Jan/Apr 2026) that can produce routine sell‑to‑cover flows but do not imply discretionary selling; no pledging allowed reduces alignment risk .
  • Change-in-control economics: Double-trigger severance with full equity acceleration under CoC termination protects management continuity while avoiding single-trigger windfalls; no excise tax gross-ups aligns with governance best practices .
  • Pay-for-performance lens: Company-level metrics (EPS, quality, enterprise goals; profitability and TSR in PSUs) indicate an incentive framework geared to earnings quality and operational outcomes; 2024 payout levels reflect strong execution but investors may weigh this against TSR trajectory and macro policy volatility in managed care .
  • Governance and ownership: Prohibitions on hedging/pledging and robust clawbacks plus stock ownership guidelines enhance alignment; McNally’s disclosed equity inventory suggests meaningful “skin in the game” across time horizons .

Sources

  • Centene 2025 Definitive Proxy Statement (DEF 14A), filed Mar 27, 2025: executive officers, compensation programs, and corporate performance highlights .
  • Centene 2024 Form 10-K (filed Feb 18, 2025): executive officers roster including McNally .
  • Insider Form 3 (filed Feb 18, 2025) for Tanya M. McNally: beneficial ownership and detailed RSU/PSU vesting schedules .
  • Executive Severance and Change-in-Control Plan summaries and execution (company signatory: Chief People Officer) .